Antimicrobial and antibiofilm activity of Lys-[Trp6]hy-a1 combined with ciprofloxacin against gram-negative bacteria
Nenhuma Miniatura disponível
Data
2020-01-01
Autores
Carneiro, Victor Alves
de Oliveira, Simone Torres
Silva, Rondinely Lima
Duarte, Humberlania de Sousa
Silva, Maria Laína
Matos, Maria Nágila Carneiro
Cavalcante, Rafaela Mesquita Bastos
Figueira, Ciro Siqueira
Lorenzón, Esteban Nicolás
Cilli, Eduardo Maffud [UNESP]
Título da Revista
ISSN da Revista
Título de Volume
Editor
Resumo
Background: Ciprofloxacin (Cip) is the most commonly used quinolone in clinical prac-tice; however large-scale use has favored the increase of multiresistant pathogenic microorganisms. Antimicrobial peptides (AMPs) appear to be a promising alternative in potentiating these conven-tional drugs. Objective: The aim of this study was to evaluate the effect of the peptide Lys-[Trp6]hy-a1 (lys-a1) on the antimicrobial and antibiofilm activity of ciprofloxacin against clinically relevant gram-nega-tive bacteria. Methods: The antimicrobial effects of Cip and lys-a1 were assessed by determining the minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs). The synergistic action of Cip and lys-a1 was determined by checkerboard assay. The time-kill curve was con-structed for the Cip/lys-a1 combination against Pseudomonas aeruginosa ATCC 9027. The antibio-film activity of this combination was analyzed by crystal violet, colony-forming unit count and atomic force microscopy (AFM). Results: The data demonstrated that lys-a1 was able to inhibit planktonic growth of strains of P. aeruginosa and Klebsiella pneumoniae both at 125 μg/mL. The fractional inhibitory concentration index (FICi) showed a synergistic effect between Cip and lys-a1 against P. aeruginosa, decreasing the MICs of the individual antimicrobial agents by 4-and 8-fold, respectively. This effect was also observed for the death kinetics and antibiofilm activity. Analysis of the early biofilms (6 h) as well as isolated cells by AFM images evidenced the cell perturbation caused by Cip/lys-a1 treatment. Conclusion: These data suggest that lys-a1 has biotechnological potential as a therapeutic tool for the treatment of infections caused by clinically relevant microorganisms, especially P. aeruginosa.
Descrição
Palavras-chave
Antibiofilm activity, Antimicrobial peptide, Ciprofloxacin, Lys-a1, Pseudomonas aeruginosa, Synergism
Como citar
Protein and Peptide Letters, v. 27, n. 11, p. 1124-1131, 2020.